STEPHANIE MANDOS: Open Payments
NPI 1417472333 · BROOMALL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$141 in 6 payments from 5 companies in 2025. Trend: 2023 $260 · 2024 $527 · 2025 $141
Food & beverage: $141
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $14 |
Products named: REXULTI, TRELEGY ELLIPTA, INGREZZA, INSPIRE, TERIPARATIDE.
Industry payments across PA — which companies pay providers there.
